|
|
Volumn 35, Issue 6, 2000, Pages 1513-1515
|
|
Acute myocardial infarction: Are diabetics different?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
HEMOGLOBIN A1C;
INSULIN;
PLATELET DERIVED GROWTH FACTOR;
SOMATOMEDIN;
ACUTE HEART INFARCTION;
ATHEROSCLEROSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DILATATION;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
EDITORIAL;
ENDOTHELIUM;
FIBRINOLYTIC THERAPY;
GLUCOSE BLOOD LEVEL;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
MORTALITY;
PRIORITY JOURNAL;
RESTENOSIS;
SURVIVAL;
THROMBOCYTE AGGREGATION;
THROMBOGENESIS;
TREATMENT OUTCOME;
AGED;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
CORONARY ANGIOGRAPHY;
DIABETIC ANGIOPATHIES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
SURVIVAL RATE;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
|
|
EID: 0034071545
PISSN: 07351097
EISSN: None
Source Type: Journal
DOI: 10.1016/S0735-1097(00)00578-7 Document Type: Editorial |
|
Times cited : (17)
|
|
References (23)
|
